Kadcyla (ado-trastuzumab emtansine) 产品说明书 Proprietary & Confidential © 2022 Magellan Health, Inc. Kadcyla® (ado-trastuzumab emtansine) (Intravenous) Document Number: IC-0092 Last Review Date: 07/20/2022 Date of Origin: 05/16/2013 Dates Reviewed: 07/2013, 11/2013, 12/2013, 03/...
Jorgensen JT. Role of human epidermal growth factor receptor 2 in gastric cancer: Biological and pharmacological aspects. World J Gastroenterol. 2014;20(16):4526-4535. Krop IE, LoRusso P, Miller KD, et al. A phase II study of trastuzumab emtansine in patients with human epidermal growth fact...